Loading the player...
Closed Captioning / Subtitles Available
Information
Advanced Wound Therapies
Copyright :
With so many existing and emerging treatment modalities to expedite wound healing in acute and chronic wounds, it is difficult to keep up with them all. This presentation reviews the mechanism of action, patient selection, and usage of various methods of advanced wound treatment including negative pressure wound therapy, transcutaneous and hyperbaric oxygen, grafts and matrices, autologous treatments, energy therapies. Completion of the presentation will leave attendees with an understanding of adjunctive interventions to use in combination with biofilm based wound bed preparation to maximize positive outcomes for patients.
Laura Swoboda, DNP, APNP, FNP-BC, FNP-C, CWSP
Laura Swoboda, DNP, APNP, FNP-BC, FNP-C, CWSP, is a family nurse practitioner and translational scientist at SkinGurus in Milwaukee, WI. Dr Swoboda is on the editorial board of American Nurse Journal, the official journal of the American Nurses Association, and WOUNDS journal. They represent North America on the International Skin Tear Advisory Panel and are President of the Milwaukee Metro Nurse Practitioner Association. Dr Swoboda has won two career lifetime achievement awards under the age of forty as a fellow of both the American Association of Nurse Practitioners and the Wound Ostomy Continence Nurses Association.
Speaker Disclosures:
Financial: Dr. Laura Swoboda has employment relationships with Third Coast Vascular, MCHC, Cathage College, Skin Gurus, and The Healing Institute. She receives a speaking honorarium and consulting fee from Histologics, Hartmann, HMP, Essity, Convatec, Aroa, AOTI, Innovacyn, Solventum, Smith & Nephew. Dr. Swoboda receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Laura Swoboda serves on the board of directors for the Wound Ostomy Continence Certification Board. She is an editorial board member of Wound Care Learning Network. Dr. Swoboda previously was a consultant for Essity and Innovacyn.
